Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Breast 1

Conditions

Ovarian Neoplasms 4Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Sarcoma 1Neoplasm Invasiveness 1Myofibroma 1Hereditary Breast and Ovarian Cancer Syndrome 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Disease 1Carcinoma, Ovarian Epithelial 1

Interventions

Radiotherapy 7Brachytherapy 6Surveys and Questionnaires 4Magnetic Resonance Spectroscopy 4durvalumab 3Radiosurgery 3Methods 3tremelimumab 2aldesleukin 2Topotecan 2Radiation 2Palliative Care 2Paclitaxel 2Immunoglobulin G 2Gemcitabine 2Early Intervention, Educational 2Disulfides 2Dehydroepiandrosterone 2Counseling 2Capecitabine 2Bevacizumab 2Behavior Therapy 2Adoptive Transfer 2zimberelimab 1temsirolimus 1talazoparib 1rocakinogene sifuplasmid 1liposomal doxorubicin 1fludarabine phosphate 1dostarlimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Vaginal Neoplasms × CA-125 Antigen × Clear all
NCT00005095 2025-02-28

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Northwestern University

Recruiting
6,000 enrolled
BreastGynecologicSarcoma

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Sarcoma, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Myofibroma, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡